{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T21:06:46Z","timestamp":1750280806039,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Atrial septal defect (ASD) is one of the common congenital heart defects. Its management has transformed dramatically in the last 4 decades with the transition from surgical to percutaneous transcatheter closure for most secundum-type ASDs. Various devices are available for transcatheter closure of ASD with Amplatzer atrial septal occluder being most commonly used worldwide. Cocoon septal occlude has a nanocoating of platinum using nano-fusion technology over nitinol framework that imparts better radiopacity and excellent biocompatibility and prevents leaching of nickel into circulation, and by smoothening nitinol wire makes this device very soft and smooth. The aim of this study was to evaluate feasibility, effectiveness, safety, and long-term outcome of transcatheter closure of ASD using Cocoon septal occluder (Vascular Innovation, Thailand).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All patients undergoing transcatheter closure of hemodynamically significant ASD between September 2012 and July 2019 in our institute were included into this single-center, prospective study. Exclusion criteria were defect\u2009&gt;\u200940\u00a0mm, unsuitable anatomy, Eisenmenger syndrome, and anomalous pulmonary venous return. Three hundred and twenty patients underwent device closure, of which 238 (74%) were female. The mean age was 14.6\u00a0years (range 6\u201329), and the median weight was 30.2\u00a0kg (range 10\u201353\u00a0kg). Procedure was performed under fluoroscopy using transthoracic and transesophageal echocardiography in 298 (93.1%) and 22(6.9%) patients, respectively. Balloon-assisted technique was used, when septal defect was\u2009\u2265\u200934\u00a0mm, in 9 (2.8%) patients. The mean diameter of defect and device was 21.4\u00a0mm (range 12\u201336\u00a0mm) and 26.9\u00a0mm (range 14\u201340\u00a0mm), respectively. Aortic rim was absent in 11 (3.4%) patients. Primary success was achieved in 312 (97.5%) patients. Early embolization to right ventricle was noted in 2 (0.6%) patients. In both cases, 40-mm device was attempted for defect of 36\u00a0mm with inadequate aortic rim using balloon-assisted technique. One (0.3%) patient developed perforation of right atrium. All were surgically repaired. Three (0.9%) patients developed complete heart block following device deployment requiring device retrieval. Two patients had had moderate residual shunt at 6\u00a0months of follow-up. After mean follow-up of 50.92\u00a0months (range 12.5\u201389\u00a0months), no erosion, allergic reactions to nickel, or other major complications were reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Percutaneous transcatheter closure of ASD by Cocoon septal occluder (up to 36\u00a0mm) is safe and feasible with high success rate and without any significant device-related major complications over long-term follow-up. With unique device design and excellent long-term safety, it could be preferred dual-disk occluder for transcatheter closure of atrial septal defect. In most of the patients, ASD device can be safely deployed under transthoracic echocardiographic guidance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43044-022-00298-2","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T06:02:45Z","timestamp":1660370565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transcatheter closure of secundum atrial septal defect using Cocoon septal occluder: immediate and long-term results"],"prefix":"10.1186","volume":"74","author":[{"given":"Santosh Kumar","family":"Sinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmodullah M.","family":"Razi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0497-7367","authenticated-orcid":false,"given":"Najeeb Ullah","family":"Sofi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj Kumar","family":"Rohit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umeshwar","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awadhesh Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohit","family":"Sachan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puneet","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"key":"298_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/heart.87.3.256","volume":"87","author":"CJ McMahon","year":"2002","unstructured":"McMahon CJ, Feltes TF, Fraley JK, Bricker JT, Grifka RG, Tortoriello TA, Blake R, Bezold L (2002) Natural history of growth of secundum atrial septal defects and implications for transcatheter closure. Heart 87:256\u2013259","journal-title":"Heart"},{"key":"298_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1540-8183.2007.00216.x","volume":"20","author":"A Patel","year":"2007","unstructured":"Patel A, Lopez K, Banerjee A, Joseph A, Cao QL, Hijazi ZM (2007) Transcatheter closure of atrial septal defects in adults >= 40 years of age: Immediate and follow-up results. J Interv Cardiol 20:82\u201388","journal-title":"J Interv Cardiol"},{"key":"298_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijcard.2017.03.073","volume":"241","author":"PA Villablanca","year":"2017","unstructured":"Villablanca PA, Briston DA, Rodes-Cabau J, Briceno DF, Rao G, Aljoudi M et al (2017) Treatment options for the closure of secundum atrial septal defects: a systematic review andmeta-analysis. Int J Cardiol 241:149\u2013155","journal-title":"Int J Cardiol"},{"issue":"11","key":"298_CR4","doi-asserted-by":"publisher","first-page":"1315.e11","DOI":"10.1016\/j.cjca.2016.02.068","volume":"32","author":"Z Jalal","year":"2016","unstructured":"Jalal Z, Hascoet S, Baruteau AE, Iriart X, Kreitmann B, Boudjemline Y et al (2016) Long-term complications after transcatheter atrial septal defect closure: a review of the medical literature. Can J Cardiol 32(11):1315.e11\u20138","journal-title":"Can J Cardiol"},{"key":"298_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ijcard.2014.09.006","volume":"177","author":"BD Thanopoulos","year":"2014","unstructured":"Thanopoulos BD, Biasco L, Dardas P et al (2014) Catheter closure of atrial septal defects using the Cocoon septal occluder: preliminary results of a European multicenter study. Int J Cardiol 177:418\u2013422","journal-title":"Int J Cardiol"},{"key":"298_CR6","first-page":"1127","volume":"96","author":"K Lairakdomrong","year":"2013","unstructured":"Lairakdomrong K, Srimahachota S, Lertsapcharoen P, Chaipromrasit J, Boonyyarataveij S, Kaewsukkho P et al (2013) Clinical results of large secundum atrial septal defects in adult using percutaneous Cocoon atrial septal occluder. J Med Assoc Thai 96:1127\u20131134","journal-title":"J Med Assoc Thai"},{"key":"298_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ccd.20443","volume":"66","author":"KM Carlson","year":"2005","unstructured":"Carlson KM, Justino H, O\u2019Brien RE et al (2005) Transcatheter atrial septal defect closure: Modified balloon sizing technique to avoid overstretching the defect and oversizing the amplatzer septal occluder. Catheter Cardiovasc Interv 66:390\u2013396","journal-title":"Catheter Cardiovasc Interv"},{"key":"298_CR8","unstructured":"Qbandi MA, Cao QL, Hijari ZA. Atrial septal defect: Amplatzer- type ASD occluders. Interventions in Structural, Valvular, and Congenital Heart Disease 2nd edn New York: CRC Press, Taylor & Francis Group; 2015;436\u201347"},{"key":"298_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ccd.20248","volume":"64","author":"BV Dalvi","year":"2005","unstructured":"Dalvi BV, Pinto RJ, Gupta A (2005) New technique for device closure of large atrial septal defects. Catheter Cardiovasc Interv 64:102\u2013107","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"298_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1017\/S1047951100004169","volume":"7","author":"PC Bjornstad","year":"1997","unstructured":"Bjornstad PC, Masura J, Thaulow E et al (1997) Interventional closure of atrial septal defect with Amplatzer device: first clinical experience. Cardiol Young 7(3):277\u2013283","journal-title":"Cardiol Young"},{"issue":"1","key":"298_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1067\/mtc.2003.125","volume":"125","author":"K Fukahara","year":"2003","unstructured":"Fukahara K, Minami K, Reiss N, Fassbender D, Koerfer R (2003) Systemic allergic reaction to the percutaneous patent foramen ovale occluder. J Thorac Cardiovasc Surg 125(1):213\u2013214","journal-title":"J Thorac Cardiovasc Surg"},{"key":"298_CR12","first-page":"324","volume":"3","author":"HZ Ansari","year":"2013","unstructured":"Ansari HZ, Sadanandan S (2013) Allergic reaction to percutaneously placed Amplatzer device for symptomatic patent foramen ovale. J Clin Case Rep 3:324\u2013326","journal-title":"J Clin Case Rep"},{"issue":"5","key":"298_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.4244\/EIJV9I5A100","volume":"9","author":"X Freixa","year":"2013","unstructured":"Freixa X, Ibrahim R, Chan J et al (2013) Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale. EurIntervention 9(5):629\u2013635","journal-title":"EurIntervention"},{"key":"298_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2147\/MDER.S49368","volume":"8","author":"N Bissessor","year":"2015","unstructured":"Bissessor N (2015) Current perspectives in percutaneous atrial septal defect closure devices. Med Devices Evid Res 8:297\u2013303","journal-title":"Med Devices Evid Res"},{"issue":"4","key":"298_CR15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/joic.12214","volume":"28","author":"XB Pan","year":"2015","unstructured":"Pan XB, Ou-Yang WB, Pang KJ, Zhang FW, Wang SZ, Liu Y, Zhang DW, Guo GL, Tian PS, Hu SS (2015) Percutaneous closure of atrial septal defects under transthoracic echocardiography guidance without fluoroscopy or intubation in children. J Interv Cardiol 28(4):390\u2013395","journal-title":"J Interv Cardiol"},{"issue":"12","key":"298_CR16","first-page":"e511","volume":"7","author":"GS Li","year":"2012","unstructured":"Li GS, Li HD, Yang J, Zhang WQ, Hou ZS, Li QC, Zhang Y (2012) Feasibility and safety of transthoracic echocardiography-guided transcatheter closure of atrial septal defects with deficient superior-anterior rims. PLoS ONE 7(12):e511\u2013e517","journal-title":"PLoS ONE"},{"key":"298_CR17","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1016\/j.ijcard.2013.05.011","volume":"168","author":"BD Thanopoulos","year":"2013","unstructured":"Thanopoulos BD, Dardas P, Ninios V et al (2013) Transcatheter closure of large atrial septal defects with deficient aortic or posterior rims using the \u201cGreek maneuver\u201d. A multicenter study. Int J Cardiol 168:3643\u20133646","journal-title":"Int J Cardiol"},{"key":"298_CR18","doi-asserted-by":"publisher","first-page":"S2909","DOI":"10.21037\/jtd.2018.02.19","volume":"10","author":"SY Jung","year":"2018","unstructured":"Jung SY, Choi JY (2018) Transcatheter closure of atrial septal defect: principles and available devices. J Thorac Dis 10:S2909\u2013S2922","journal-title":"J Thorac Dis"},{"key":"298_CR19","first-page":"21","volume":"4","author":"AA Pillai","year":"2014","unstructured":"Pillai AA, Rangaswamy Balasubramanian V et al (2014) Utility of balloon assisted technique in trans catheter closure of very large (>35 mm) atrial septal defects. Cardiovasc Diagn Ther 4:21\u201327","journal-title":"Cardiovasc Diagn Ther"},{"key":"298_CR20","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/S0735-1097(02)01862-4","volume":"39","author":"ZD Du","year":"2002","unstructured":"Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz L (2002) Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol 39:1836\u20131844","journal-title":"J Am Coll Cardiol"},{"key":"298_CR21","first-page":"e63","volume":"25","author":"E Mart\u00ednez-Quintana","year":"2016","unstructured":"Mart\u00ednez-Quintana E, Rodr\u00edguez-Gonz\u00e1lez F (2016) Risks factors for atrial septal defect occlusion device migration. Int J Angiol 25:e63\u2013e65","journal-title":"Int J Angiol"},{"key":"298_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1536\/ihj.15-065","volume":"56","author":"WC Lee","year":"2015","unstructured":"Lee WC, Fang CY, Huang CF et al (2015) Predictors of atrial septal defect occluder dislodgement. Int Heart J 56:428\u2013431","journal-title":"Int Heart J"},{"key":"298_CR23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0735-1097(02)01711-4","volume":"39","author":"M Chessa","year":"2002","unstructured":"Chessa M, Carminati M, Butera G, Bini RM, Drago M, Rosti L, Giamberti A, Pome G, Bossone E, Frigiola A (2002) Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 39:1061\u20131065","journal-title":"J Am Coll Cardiol"},{"key":"298_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1177\/000331970305400115","volume":"54","author":"PK Verma","year":"2003","unstructured":"Verma PK, Thingnam SK, Sharma A, Taneja JS, Varma JS, Grover A (2003) Delayed embolization of Amplatzer septal occluder device: an unknown entity-a case report. Angiology 54:115\u2013118","journal-title":"Angiology"},{"issue":"3","key":"298_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ihj.2014.03.013","volume":"66","author":"MK Rohit","year":"2014","unstructured":"Rohit MK, Puri K, Vadivelu R (2014) Reversible complete atrioventricular block after percutaneous ASD device closure in a child <15 kg. Indian Heart J 66(3):366\u2013369","journal-title":"Indian Heart J"},{"key":"298_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/hrt.82.3.300","volume":"82","author":"KC Chan","year":"1999","unstructured":"Chan KC, Godman MJ, Walsh K, Wilson N, Redington A, Gibbs JL (1999) Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart 82:300\u2013306","journal-title":"Heart"},{"issue":"Suppl 24","key":"298_CR27","doi-asserted-by":"publisher","first-page":"S2923","DOI":"10.21037\/jtd.2018.07.128","volume":"10","author":"A Faccini","year":"2018","unstructured":"Faccini A, Butera G (2018) Atrial septal defect (ASD) device trans-catheter closure: limitations. J Thorac Dis 10(Suppl 24):S2923\u2013S2930","journal-title":"J Thorac Dis"},{"key":"298_CR28","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.jacc.2003.12.042","volume":"43","author":"K Suda","year":"2004","unstructured":"Suda K, Raboisson MJ, Piette E, Dahdah NS, Mir J (2004) Reversible atrioventricular block associated with closure of atrial septal defects using the Amplatzer device. J Am Coll Cardiol. 43:1677\u20131682","journal-title":"J Am Coll Cardiol."},{"key":"298_CR29","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.jacc.2004.12.072","volume":"45","author":"A Divekar","year":"2005","unstructured":"Divekar A, Gaamangwe T, Shaikh N, Raabe M, Ducas J (2005) Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 45:1213\u20131218","journal-title":"J Am Coll Cardiol"},{"key":"298_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.hjc.2020.12.009","author":"BVD Thanopoulos","year":"2021","unstructured":"Thanopoulos BVD, Soendergaard L, Ngugen HL, Marasini M, Giannopoulos A, Bompotis GS, Thonghong T, Krishnamoorthy KM, Placid S, Deleanou D, Toutouzas KP (2021) International experience with the use of Cocoon septal occluder for closure of atrial septal defects. Hell J Cardiol. https:\/\/doi.org\/10.1016\/j.hjc.2020.12.009","journal-title":"Hell J Cardiol"},{"key":"298_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1067\/mhj.2003.7","volume":"145","author":"MW Ries","year":"2003","unstructured":"Ries MW, Kampmann C, Rupprecht HJ et al (2003) Nickel release after implantation of the Amplatzer occluder. Am Heart J 145:737\u2013741","journal-title":"Am Heart J"},{"key":"298_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5414\/CPP44107","volume":"44","author":"M Burian","year":"2006","unstructured":"Burian M, Neumann T, Weber M et al (2006) Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder. Int J Clin Pharmacol Ther 44:107\u2013112","journal-title":"Int J Clin Pharmacol Ther"},{"key":"298_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1067\/mtc.2003.125","volume":"125","author":"K Fukahara","year":"2003","unstructured":"Fukahara K, Kazutomo M, Riess N et al (2003) Systemic allergic reaction to the percutaneous patent foramen ovale occluder. J Thorac Cardiovasc Surg 125:213\u2013214","journal-title":"J Thorac Cardiovasc Surg"},{"key":"298_CR34","first-page":"681","volume":"16","author":"HR Singh","year":"2004","unstructured":"Singh HR, Turner DR, Forbes TJ (2004) Nickel allergy and the Amplatzer septal occluder. J Invasive Cardiol 16:681\u2013682","journal-title":"J Invasive Cardiol"},{"key":"298_CR35","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.amjcard.2007.10.034","volume":"101","author":"J Rodes-Cabau","year":"2008","unstructured":"Rodes-Cabau J, Mineau S, Marrero A et al (2008) Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale. Am J Cardiol 101:688\u2013692","journal-title":"Am J Cardiol"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-022-00298-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-022-00298-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-022-00298-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T06:04:47Z","timestamp":1660370687000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-022-00298-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["298"],"URL":"https:\/\/doi.org\/10.1186\/s43044-022-00298-2","relation":{},"ISSN":["2090-911X"],"issn-type":[{"type":"electronic","value":"2090-911X"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"12 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LPSIC Ethical committee (Institutional ethical committee) approved the study on 5th March 2012 with reference number 07\/2012.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent to participate in the study was taken from patients or their legal guardians in case patient was less than 18\u00a0years old.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent was taken from the patients for the procedure and publication. In case patient was less than 18\u00a0years old, consent was taken from legal guardian.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}